Hazelwood Mallinckrodt HQ Gets $2 Million Investment, Now Publicly Traded

You may have driven past Covidien on James S. McDonell Boulevard and noticed a different sign in front of the campus.

That's because the company is now making a distinction between Covidien and its pharmaceutical arm, Mallinckrodt. What you see when you drive past is a purple and white Mallinckrodt sign; however, Covidien still has a presence in Hazelwood. There are still Covidien buildings on Campus Parkway and near Phantom Drive.

Hazelwood Patch brought the news in June of the new standalone company being approved via Covidien's board of directors. See here: Mallinckrodt Officially Its Own Company

The company might also be bringing about 150 new jobs to Hazelwood.

That has led to a lot of contention in the area as the aftermath of that project has been a longstanding cleanup. Many in the area also believe local cancer anomalies are linked to the poor management of the remnants of the uranium as it was disposed of throughout the northern portions of St. Louis City and St. Louis County.

Lynn Phillips, Mallinckrodt's media relations manager, spoke with Hazelwood Patch about why Covidien decided to bring back the Mallinckrodt name to the same area, local people feel it hurt the most.

St. Louis facilities include manufacturing plants downtown and in Maryland Heights, R&D facility in Webster Groves and corporate offices in Hazelwood.